Please assess the completion status of the following clinical trial:

Trial Title: Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female, at least 18 years old~* Patients with clinical suspected pulmonary embolism~* Patient willing and able to provide informed consent~Exclusion Criteria:~* Contraindications to pulmonary ventilator-perfusion tomoscintigraphy~* All types of thrombolytic or anticoagulant treatment~* Diagnosis of pulmonary embolism established prior to inclusion in the study~* Massive pulmonary embolism (systolic pressure \< 90 mm Hg)~* Pregnancy~* Breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- Presence of pulmonary embolism (Type: None): ≥ 1 noninfused and normoventilated segment(s) by pulmonary tomoscintigraphy
- No pulmonary embolism (Type: None): Pulmonary perfusion without anomaly (segmental or sub-segmental) by pulmonary tomoscintigraphy

Based on this trial design, predict the completion outcome and termination type (if applicable).